Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $4.89M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −99.0% to −18.6% across the middle 80 percent of the group, with a median of −71.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.66M | Micro cap | +7.14% |
| VRCI.L | Verici Dx plc | $6.99M | Micro cap | −57.14% |
| VNRX | VolitionRx Limited | $4.89M | Micro cap | −97.47% |
| ADTX | Aditxt, Inc. | $2.59M | Micro cap | −100.00% |
| 2CUREX.ST | 2cureX AB (publ) | $1.34M | Micro cap | −71.79% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.